• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重症肌无力中自身免疫性疾病的频率:系统评价。

Frequency of autoimmune diseases in myasthenia gravis: a systematic review.

机构信息

Department of Neurology, Third Affiliated Hospital, Guangxi Medical University, Nanning, PR China.

出版信息

Int J Neurosci. 2011 Mar;121(3):121-9. doi: 10.3109/00207454.2010.539307. Epub 2010 Dec 13.

DOI:10.3109/00207454.2010.539307
PMID:21142828
Abstract

The course of myasthenia gravis (MG) may get complicated by the development of other autoimmune diseases. Estimates of the frequency of autoimmune diseases will help inform patients and physicians, direct health policy discussion, provide etiologic clues, and optimize the management of MG. However, the frequency of autoimmune diseases in people with MG is still uncertain. A systematic search for English language studies was conducted by MEDLINE and EMBASE from 1960 through 2010. Incidence studies and case series of all MG subtypes with information about autoimmune diseases were included; 25 studies met the inclusion criteria. Although there was considerable heterogeneity, the pooled estimate of the coexisting autoimmune diseases in MG was 13% (95% confidence interval, 12%-14%). Autoimmune thyroid disease seems to occur more frequently than other autoimmune conditions in MG patients. Heterogeneity in study estimates could be explained by ascertainment bias and case mix. Furthermore, autoimmune diseases occurred significantly more often in females and anti-acetylcholine receptor seropositive MG patients. Patients with MG have an increased frequency of coexisting autoimmune diseases. Autoimmune diseases seem to occur more often in female and seropositive MG patients. Further research is needed to expand our understanding of these associations.

摘要

重症肌无力 (MG) 的病程可能会因其他自身免疫性疾病的发展而变得复杂。对自身免疫性疾病的频率估计将有助于告知患者和医生,指导卫生政策讨论,提供病因线索,并优化 MG 的管理。然而,MG 患者自身免疫性疾病的频率仍不确定。通过 MEDLINE 和 EMBASE 对 1960 年至 2010 年的英语文献进行了系统检索。纳入了所有 MG 亚型的发病率研究和病例系列,这些研究都提供了自身免疫性疾病的信息;有 25 项研究符合纳入标准。尽管存在很大的异质性,但 MG 患者共存自身免疫性疾病的合并估计值为 13%(95%置信区间,12%-14%)。自身免疫性甲状腺疾病在 MG 患者中的发生频率似乎高于其他自身免疫性疾病。研究估计值的异质性可以用检出偏倚和病例组合来解释。此外,女性和抗乙酰胆碱受体阳性的 MG 患者发生自身免疫性疾病的频率显著更高。MG 患者共存自身免疫性疾病的频率增加。自身免疫性疾病在女性和血清阳性的 MG 患者中似乎更常见。需要进一步研究来扩大我们对这些关联的理解。

相似文献

1
Frequency of autoimmune diseases in myasthenia gravis: a systematic review.重症肌无力中自身免疫性疾病的频率:系统评价。
Int J Neurosci. 2011 Mar;121(3):121-9. doi: 10.3109/00207454.2010.539307. Epub 2010 Dec 13.
2
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
3
Levetiracetam add-on for drug-resistant focal epilepsy: an updated Cochrane Review.左乙拉西坦添加治疗耐药性局灶性癫痫:Cochrane系统评价的更新版
Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD001901. doi: 10.1002/14651858.CD001901.pub2.
4
Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta-analysis.胆碱酯酶抑制剂治疗血管性痴呆和其他血管性认知障碍:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Feb 22;2(2):CD013306. doi: 10.1002/14651858.CD013306.pub2.
5
Taxane monotherapy regimens for the treatment of recurrent epithelial ovarian cancer.紫杉烷类单药治疗方案用于复发性上皮性卵巢癌。
Cochrane Database Syst Rev. 2022 Jul 12;7(7):CD008766. doi: 10.1002/14651858.CD008766.pub3.
6
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
7
Systemic interventions for treatment of Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN overlap syndrome.全身性治疗史蒂文斯-约翰逊综合征(SJS)、中毒性表皮坏死松解症(TEN)和 SJS/TEN 重叠综合征。
Cochrane Database Syst Rev. 2022 Mar 11;3(3):CD013130. doi: 10.1002/14651858.CD013130.pub2.
8
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂在患有早期(1 至 3 期)非糖尿病慢性肾脏病的成人中的应用。
Cochrane Database Syst Rev. 2023 Jul 19;7(7):CD007751. doi: 10.1002/14651858.CD007751.pub3.
9
Prophylactic mastectomy for the prevention of breast cancer.预防性乳房切除术用于预防乳腺癌。
Cochrane Database Syst Rev. 2004 Oct 18(4):CD002748. doi: 10.1002/14651858.CD002748.pub2.
10
Pain management for medical abortion before 14 weeks' gestation.孕 14 周前药物流产的疼痛管理。
Cochrane Database Syst Rev. 2022 May 13;5(5):CD013525. doi: 10.1002/14651858.CD013525.pub2.

引用本文的文献

1
Telitacicept as double-targeted therapy for myasthenia gravis coexisting with connective tissue disease: three case reports.替利妥昔单抗作为重症肌无力合并结缔组织病的双靶点治疗:三例病例报告
Front Immunol. 2025 May 27;16:1552521. doi: 10.3389/fimmu.2025.1552521. eCollection 2025.
2
Association of Myasthenia Gravis With Autoimmune Thyroid Disease: A Bidirectional Mendelian Randomization Study.重症肌无力与自身免疫性甲状腺疾病的关联:一项双向孟德尔随机化研究。
Brain Behav. 2025 Jan;15(1):e70235. doi: 10.1002/brb3.70235.
3
Unveiling the uncommon: a captivating case of multiple autoimmune syndrome.
揭示罕见病例:一例引人入胜的多重自身免疫综合征病例
Arch Clin Cases. 2024 Oct 9;11(3):83-85. doi: 10.22551/2024.44.1103.10293. eCollection 2024.
4
Analysis of clinical features and outcomes in patients with ocular myasthenia gravis according to anti-acetylcholine receptor antibody-seropositivity.根据抗乙酰胆碱受体抗体阳性分析眼肌型重症肌无力患者的临床特征和结局。
Jpn J Ophthalmol. 2024 Nov;68(6):681-687. doi: 10.1007/s10384-024-01125-8. Epub 2024 Oct 2.
5
A patient treated with ofatumumab for myasthenia gravis in conjunction with systemic lupus erythematosus and thyroid carcinoma.一名患有重症肌无力、系统性红斑狼疮和甲状腺癌的患者接受了奥法木单抗治疗。
Intractable Rare Dis Res. 2024 Aug 31;13(3):195-198. doi: 10.5582/irdr.2024.01022.
6
Prevalences of Other Non-Thyroid Autoimmune Diseases and Factor Associated with Their Presence in Ocular Myasthenia Gravis.其他非甲状腺自身免疫性疾病的患病率及其与眼肌型重症肌无力共存的相关因素。
Clin Ophthalmol. 2024 Apr 25;18:1125-1132. doi: 10.2147/OPTH.S458979. eCollection 2024.
7
Triple-seronegative myasthenia gravis: clinical and epidemiological characteristics.三阴性重症肌无力:临床与流行病学特征
Arq Neuropsiquiatr. 2024 Jan;82(1):1-7. doi: 10.1055/s-0044-1779052. Epub 2024 Feb 5.
8
Case report: Coexistence of triple-seronegative myasthenia gravis and pathology-proven cryptogenic organizing pneumonia.病例报告:三阴性重症肌无力与病理证实的隐源性机化性肺炎并存。
Front Neurol. 2023 Nov 16;14:1295374. doi: 10.3389/fneur.2023.1295374. eCollection 2023.
9
Residual serum fibrinogen as a universal biomarker for all serotypes of Myasthenia gravis.残余血清纤维蛋白原作为重症肌无力所有血清型的通用生物标志物。
Sci Rep. 2023 Dec 1;13(1):21229. doi: 10.1038/s41598-023-47559-x.
10
Myasthenia gravis and five autoimmune diseases: a bidirectional Mendelian randomization study.重症肌无力与五种自身免疫性疾病:一项双向孟德尔随机化研究。
Neurol Sci. 2024 Apr;45(4):1699-1706. doi: 10.1007/s10072-023-07163-3. Epub 2023 Nov 1.